Lyles CM - Search Results

1

Rectal mucosal ornithine decarboxylase activity is not a useful marker of risk for colorectal neoplasia.

Sandler RS, Ulshen MH, Lyles CM, McAuliffe CA, Fuller CR. Sandler RS, et al. Among authors: lyles cm. Dig Dis Sci. 1992 Nov;37(11):1718-24. doi: 10.1007/BF01299865. Dig Dis Sci. 1992. PMID: 1425072

2

Reproducibility and variability of the rectal mucosal proliferation index using proliferating cell nuclear antigen immunohistochemistry.

Lyles CM, Sandler RS, Keku TO, Kupper LL, Millikan RC, Murray SC, Bangdiwala SI, Ulshen MH. Lyles CM, et al. Cancer Epidemiol Biomarkers Prev. 1994 Oct-Nov;3(7):597-605. Cancer Epidemiol Biomarkers Prev. 1994. PMID: 7827591

3

Childhood infections and the risk of inflammatory bowel disease.

Wurzelmann JI, Lyles CM, Sandler RS. Wurzelmann JI, et al. Among authors: lyles cm. Dig Dis Sci. 1994 Mar;39(3):555-60. doi: 10.1007/BF02088342. Dig Dis Sci. 1994. PMID: 8131692

4

Cigarette smoking, alcohol, and the risk of colorectal adenomas.

Sandler RS, Lyles CM, McAuliffe C, Woosley JT, Kupper LL. Sandler RS, et al. Among authors: lyles cm. Gastroenterology. 1993 May;104(5):1445-51. doi: 10.1016/0016-5085(93)90354-f. Gastroenterology. 1993. PMID: 8482454

5

Comparison of rectal mucosal proliferation measured by proliferating cell nuclear antigen (PCNA) immunohistochemistry and whole crypt dissection.

Murray SC, Sandler RS, Keku TO, Lyles CM, Millikan RC, Bangdiwala SI, Kupper LL, Jiang W, Ulshen MH. Murray SC, et al. Among authors: lyles cm. Cancer Epidemiol Biomarkers Prev. 1995 Oct-Nov;4(7):715-20. Cancer Epidemiol Biomarkers Prev. 1995. PMID: 8672987

6

Oral contraceptive use and the risk of inflammatory bowel disease.

Sandler RS, Wurzelmann JI, Lyles CM. Sandler RS, et al. Among authors: lyles cm. Epidemiology. 1992 Jul;3(4):374-8. doi: 10.1097/00001648-199207000-00014. Epidemiology. 1992. PMID: 1637902

7

Diet and risk of colorectal adenomas: macronutrients, cholesterol, and fiber.

Sandler RS, Lyles CM, Peipins LA, McAuliffe CA, Woosley JT, Kupper LL. Sandler RS, et al. Among authors: lyles cm. J Natl Cancer Inst. 1993 Jun 2;85(11):884-91. doi: 10.1093/jnci/85.11.884. J Natl Cancer Inst. 1993. PMID: 8388061

8

Persistence and clinical significance of hepatitis G virus infections in injecting drug users.

Thomas DL, Nakatsuji Y, Shih JW, Alter HJ, Nelson KE, Astemborski JA, Lyles CM, Vlahov D. Thomas DL, et al. Among authors: lyles cm. J Infect Dis. 1997 Sep;176(3):586-92. doi: 10.1086/514078. J Infect Dis. 1997. PMID: 9291303

9

The influence of drug use patterns on the rate of CD4+ lymphocyte decline among HIV-1-infected injecting drug users.

Lyles CM, Margolick JB, Astemborski J, Graham NM, Anthony JC, Hoover DR, Vlahov D. Lyles CM, et al. AIDS. 1997 Aug;11(10):1255-62. doi: 10.1097/00002030-199710000-00009. AIDS. 1997. PMID: 9256944

10

Vitamin A supplementation and human immunodeficiency virus load in injection drug users.

Semba RD, Lyles CM, Margolick JB, Caiaffa WT, Farzadegan H, Cohn S, Vlahov D. Semba RD, et al. Among authors: lyles cm. J Infect Dis. 1998 Mar;177(3):611-6. doi: 10.1086/514235. J Infect Dis. 1998. PMID: 9498439 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters